Annuncio pubblicitario
Italia markets close in 2 hours 15 minutes

  • FTSE MIB

    34.315,35
    -48,40 (-0,14%)
     

  • Dow Jones

    38.503,69
    +263,71 (+0,69%)
     

  • Nasdaq

    15.696,64
    +245,33 (+1,59%)
     

  • Nikkei 225

    38.460,08
    +907,92 (+2,42%)
     

  • Petrolio

    83,11
    -0,25 (-0,30%)
     

  • Bitcoin EUR

    61.898,25
    +7,30 (+0,01%)
     

  • CMC Crypto 200

    1.434,29
    +10,19 (+0,72%)
     

  • Oro

    2.335,70
    -6,40 (-0,27%)
     

  • EUR/USD

    1,0692
    -0,0013 (-0,12%)
     

  • S&P 500

    5.070,55
    +59,95 (+1,20%)
     

  • HANG SENG

    17.201,27
    +372,34 (+2,21%)
     

  • Euro Stoxx 50

    5.014,75
    +6,58 (+0,13%)
     

  • EUR/GBP

    0,8592
    -0,0003 (-0,03%)
     

  • EUR/CHF

    0,9755
    +0,0000 (+0,00%)
     

  • EUR/CAD

    1,4665
    +0,0048 (+0,33%)
     

Orion Corporation: Managers’ transactions – Virve Laitinen

Orion Oyj
·1 minuto per la lettura
Orion Oyj
Orion Oyj

ORION CORPORATION
MANAGERS’ TRANSACTIONS
5 August 2022 at 11.15 EEST              

Orion Corporation: Managers’ transactions – Virve Laitinen

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Orion Oyj - Managers' Transactions
____________________________________________

Person subject to the notification requirement
Name: Virve Laitinen
Position: Other senior manager

ANNUNCIO PUBBLICITARIO

Issuer: Orion Oyj
LEI: 74370029VAHCXDR7B745
Notification type: INITIAL NOTIFICATION
Reference number: 18216/4/4
____________________________________________

Transaction date: 2022-08-04
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009014377
Nature of the transaction: DISPOSAL

Transaction details
(1): Volume: 4000 Unit price: 47,00 EUR

Aggregated transactions
(1): Volume: 4000 Volume weighted average price: 47,00 EUR

Orion Corporation

Timo Lappalainen

President and CEO

   

Olli Huotari

SVP, Corporate Functions

 

                                                

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion’s pharmaceutical R&D are oncology and pain. Orion’s net sales in 2021 amounted to EUR 1,041 million and the company had about 3,350 employees at the end of the year. Orion’s A and B shares are listed on Nasdaq Helsinki.